# Curanosticum Wiesbaden-Frankfurt

Source: https://onco.cc/institutions/curanosticum/  
OnCo record `curanosticum` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Curanosticum is a nuclear medicine practice in Wiesbaden and Frankfurt led by Richard Baum, one of the pioneers of peptide receptor radionuclide therapy, offering FAPI PET and investigational radioligand therapies.

## Summary

Curanosticum Wiesbaden-Frankfurt describes itself as modern nuclear medicine in the Rhine-Main region: precise diagnostics and individual therapy from an experienced team. Led by Richard Baum, it offers FAPI PET imaging and investigational radioligand therapies alongside established theranostics, and is patient-bookable through an oncology referral.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Tags: fcct-directory
- City: Wiesbaden, DE
- Type: hospital
- Website: https://www.curanosticum.de/

## Sources

- Official website: https://www.curanosticum.de/
- Listed on Future of Cancer Care Today (Sijbrandij Foundation): https://sijbrandijfoundation.org/fcct

## Connected records

- technologies: [FAPI PET](https://onco.cc/technologies/fapi-pet/), [Lutetium-177 radioligand therapy](https://onco.cc/technologies/lu177-radioligand-therapy/), [Radioligand therapy (beta emitters)](https://onco.cc/technologies/radioligand-therapy/)

---
JSON: https://onco.cc/api/v1/entities/curanosticum.json